Publications

Articles

77. Luo W, Jin Y, Jiang Y, Yang L, Xu H, Wu D, Zhang Y, Yin L, Khan ZA, Liang G, Wang Y. Doublecortin-like kinase 1 activates NF-κB to induce inflammatory responses by binding directly to IKKβ. Cell Death Differ. 2023 Mar 13. doi: 10.1038/s41418-023-01147-8. PMID: 36914767.

76. Kum JJY, Howlett CJ, Khan ZA. Dysregulated transforming growth factor-beta mediates early bone marrow dysfunction in diabetes. Commun Biol. 2022 Oct 28;5(1):1145. doi: 10.1038/s42003-022-04112-2. PMID: 36307522.

75. Luo W, Lin K, Hua J, Han J, Zhang Q, Chen L, Khan ZA, Wu G, Wang Y, Liang G. Schisandrin B attenuates diabetic cardiomyopathy by targeting MyD88 and inhibiting MyD88-dependent inflammation. Adv Sci (Weinh). 2022 Sep 30:e2202590. doi: 10.1002/advs.202202590. PMID: 36180407

74. Lin K, Luo W, Yang N, Su L, Zhou H, Hu X, Wang Y, Khan ZA, Huang W, Wu G, Liang G. Inhibition of MyD88 attenuates angiotensin II-induced hypertensive kidney disease via regulating renal inflammation. Int Immunopharmacol. 2022 Sep 13;112:109218. doi.org/10.1016/j.intimp.2022.109218. PMID: 36116148.

73. Xu Z, Luo W, Chen L, Zhuang Z, Yang D, Qian J, Khan ZA, Guan X, Wang Y, Li X, Liang G. Ang II (Angiotensin II)-Induced FGFR1 (Fibroblast Growth Factor Receptor 1) Activation in Tubular Epithelial Cells Promotes Hypertensive Kidney Fibrosis and Injury. Hypertension. 2022 Sep;79(9):2028-2041. PMID: 35862110

72. Rogala B, Khan ZA, Jackson-Boeters L, Darling MR. Investigation of the molecular profile of granular cell tumours and schwannomas of the oral cavity. Dent J (Basel). 2022 Mar 4;10(3):38. doi: 10.3390/dj10030038. PMID: 35323240.

  

Articles

71. Cox J, Khan Z, Jackson-Boeters, Armstrong J, Darling M. Human tissue kallikreins in polymorphous adenocarcinoma – a polymerase chain reaction and immunohistochemical study. Head Neck Pathol. 2020 Jun 26. doi: 10.1007/s12105-020-01196-2. PMID: 32592124.

70. Wang Y, Luo W, Han J, Khan ZA, Fang Q, Jin Y, Chen X, Zhang Y, Wang M, Qian J, Huang W, Lum H, Wu G, Liang G. MD2 activation by direct AGE interaction drives inflammatory diabetic cardiomyopathy. Nat Commun. 2020 May 1;11(1):2148. doi: 10.1038/s41467-020-15978-3. PubMed PMID: 32358497; PubMed Central PMCID: PMC7195432.

69. Ye S, Luo W, Khan ZA, Wu G, Xuan L, Shan P, Lin K, Chen T, Wang J, Hu X, Wang S, Huang W, Liang G. Celastrol Attenuates Angiotensin II-induced Cardiac Remodeling by Targeting STAT3. Circ Res. 2020 Apr 10;126(8):1007-1023. doi: 10.1161/CIRCRESAHA.119.315861. Epub 2020 Feb 26. PubMed PMID: 32098592.

68. Zhang Y, Chen H, Zhang W, Ca Y, Shan P, Wu D, Zhang B, Liu H, Khan ZA, Liang G. Arachidonic acid inhibits inflammatory responses by binding to myeloid differentiation factor-2 (MD2) and preventing MD2/toll-like receptor 4 signaling activation. Biochim Biophys Acta Mol Basis Dis. 2020 May 1;1866(5):165683. doi: 10.1016/j.bbadis.2020.165683. Epub 2020 Jan 14. PubMed PMID: 31953218.

 

Articles
67. Biswas S, Chen S, Liang G, Feng B, Cai L, Khan ZA, Chakrabarti S. Curcumin analogues reduce stress and inflammation indices in experimental models of diabetes. Front Endocrinol (Lausanne). 2019;10:887. doi: 10.3389/fendo.2019.00887. eCollection 2019. PubMed PMID: 31920992; PubMed Central PMCID: PMC6930691.

66. Alsabbagh A, Robins TL, Harriman A, Jackson-Boeters L, Darling MR, Khan ZA, and McCord C. Surrogate markers for high risk human papillomavirus infection in oral epithelial dysplasia: a comparison of p16, Ki-67 and ProExC. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020 Mar;129(3):246-259.e1. doi: 10.1016/j.oooo.2019.09.019. Epub 2019 Oct 14. PubMed PMID: 31902664.

65. Kerr Z, Hayter A, Khan Z, Darling M. Kallikrein-related peptidase mRNA expression in adenoid cystic carcinoma of salivary glands: a polymerase chain reaction study. Head Neck Pathol. 2019 Sep 12;. doi: 10.1007/s12105-019-01076-4. [Epub ahead of print] PubMed PMID: 31515705.

64. Wang Y, Fang Q, Jin Y, Liu Z, Zou C, Yu W, Li W, Shan X, Chen R, Khan Z, Liang G.  Blockade of myeloid differentiation 2 attenuates diabetic nephropathy by reducing activation of the renin-angiotensin system in mouse kidneys. Br J Pharmacol. 2019 Jul;176(14):2642-2657. doi: 10.1111/bph.14687. Epub 2019 May 23. PubMed PMID: 30959575; PubMed Central PMCID: PMC6592858.

63. Xu Z, Zou C, Yu W, Xu S, Huang L, Khan Z, Wang J, Liang G, Wang Y. Inhibition of STAT3 activation mediated by toll-like receptor 4 attenuates angiotensin II-induced renal fibrosis and dysfunction. Br J Pharmacol. 2019 Jul;176(14):2627-2641. doi: 10.1111/bph.14686. Epub 2019 May 11. PubMed PMID: 30958891; PubMed Central PMCID: PMC6592868.

62. Qian J, Chen X, Chen X, Sun C, Jiang Y, Qian Y, Zhang Y, Khan Z, Zhou J, Liang G, Zheng C. Kaempferol reduces K63-linked polyubiquitination to inhibit nuclear factor-κB and inflammatory responses in acute lung injury in mice. Toxicol Lett. 2019 May 15;306:53-60. doi: 10.1016/j.toxlet.2019.02.005. Epub 2019 Feb 12. PubMed PMID: 30769083.

61. Morrison MD, Jackson-Boeters L, Khan ZA, Shimizu MS, Franklin JH, Fung K, Yoo JHJ, Darling MR. Identifying Candidate Biomarkers for Pleomorphic Adenoma: A Case-Control Study. Head Neck Pathol. Head Neck Pathol. 2019 Sep;13(3):286-297. doi: 10.1007/s12105-018-0959-6. Epub 2018 Aug 17. PubMed PMID: 30120721; PubMed Central PMCID: PMC6684674.

60. Ji J, Chen W, Chen R, Weng Q, Khan Z, Hu J, Chen X, Zhang Q, Zou P, Liang G. (S)-crizotinib reduces gastric cancer growth through oxidative DNA damage and triggers pro-survival Akt signal. Cell Death Dis. 2018 May 31;9(6):660. doi: 10.1038/s41419-018-0667-x. PubMed PMID: 29855474; PubMed Central PMCID: PMC5981313.

59. Chen X, Qian J, Wang L, Li J, Zhao Y, Han J, Khan Z, Chen X, Wang J, Liang G. Kaempferol attenuates hyperglycemia-induced cardiac injuries by inhibiting inflammatory responses and oxidative stress. Endocrine. 2018 Apr;60(1):83-94. doi: 10.1007/s12020-018-1525-4. Epub 2018 Feb 1. PubMed PMID: 29392616.

 

Articles
58. Zou C, Li W, Li J, Khan ZA, Pan Y, Wu X, Yin H, Wang J, Zheng C, Liang G. 11β-HSD1 inhibition ameliorates diabetes-induced cardiomyocyte hypertrophy and cardiac fibrosis through modulation of EGFR activity. Oncotarget. 2017 Nov 10;8(56):96263-96275. doi: 10.18632/oncotarget.22015. eCollection 2017 Nov 10. PubMed PMID: 29221204; PubMed Central PMCID: PMC5707098.

57. Zhuge W, Chen R, Guo G, Dong X, Khan Z, Sun X, Dai X, Chen X, Bao M, Shen X, Liang G. Costunolide specifically binds and inhibits thioredoxin reductase 1 to induce apoptosis in colon cancer. Cancer Lett. 2018 Jan 1;412:46-58. doi: 10.1016/j.canlet.2017.10.006. Epub 2017 Oct 13. PubMed PMID: 29037867.

56. Wang L, Huang Z, Huang W, Chen X, Shan P, Zhong P, Khan Z, Wang J, Fang Q, Liang G, Wang Y. Inhibition of epidermal growth factor receptor attenuates atherosclerosis via decreasing inflammation and oxidative stress. Sci Rep. 2017 Apr 4;8:45917. doi: 10.1038/srep45917. PubMed PMID: 28374780; PubMed Central PMCID: PMC5379239.

55. Darling M, Cuddy K, Woodford R, Jackson-Boeters L, Hayter A, Inkaran J, Diamandis E, and Khan Z. Kallikrein-related peptidases are expressed in odontogenic cysts and tumours – an immunohistochemical comparative study. J Investig Clin Dent. 2017 Nov;8(4). doi: 10.1111/jicd.12256. Epub 2017 Jan 4. PubMed PMID: 28054463.

54. Peng K, Pan Y, Li J, Khan ZA, Fan M, Yin H, Tong C, Zhao Y, Liang G, Zheng C. 11β-Hydroxysteroid Dehydrogenase Type 1(11β-HSD1) mediates insulin resistance through JNK activation in adipocytes. Sci Rep. 2016 Nov 14;6:37160. doi: 10.1038/srep37160. PubMed PMID: 27841334; PubMed Central PMCID: PMC5107914.

Articles
53. Kum JY and Khan ZA. Mechanisms of propranolol action in infantile hemangioma. Dermatoendocrinol. 2014 Jan-Dec;6(1):e979699. doi: 10.4161/19381980.2014.979699. eCollection 2014 Jan-Dec. PubMed PMID: 26413184; PubMed Central PMCID: PMC4580045.

52. Zeng C, Zhong P, Zhao Y, Kanchana K, Zhang Y, Khan ZA, Chakrabarti S, Wu L, Wang J, Liang G. Curcumin protects hearts from FFA-induced injury by activating Nrf2 and inactivating NF-κB both in vitro and in vivo. J Mol Cell Cardiol. 2015 Feb;79:1-12. doi: 10.1016/j.yjmcc.2014.10.002. Epub 2014 Oct 16. PubMed PMID: 25444713.

54. McArthur K, Darling MR, and Khan ZA. Establishing an in vitro model of salivary gland tumors. The Cutting Edge: a publication of the American Association of Pathologists Assistants. pathassist.org/surveys/?id=2015_eBlast_04.

51. Piccinin MA and Khan ZA. Pathophysiological role of enhanced bone marrow adipogenesis in diabetic complications. Adipocyte. 2014 Oct-Dec;3(4):263-72. doi: 10.4161/adip.32215. eCollection 2014 Oct-Dec. PubMed PMID: 26317050; PubMed Central PMCID: PMC4550679.

50. Keats EC, Dominguez JM, Grant MB, and Khan ZA. Switch from canonical to noncanonical Wnt signaling mediates high glucose-induced adipogenesis. Stem Cells. 2014 Jun;32(6):1649-60. doi: 10.1002/stem.1659. PubMed PMID: 24496952; PubMed Central PMCID: PMC4037346.

49. Kum JJY and Khan ZA. Propranolol inhibits growth of hemangioma-initiating cells but does not induce apoptosis. Pediatr Res. 2014 Mar;75(3):381-8. doi: 10.1038/pr.2013.231. Epub 2013 Dec 2. PubMed PMID: 24296797; PubMed Central PMCID: PMC3951485.

Other works
3. McArthur K, Darling MR, and Khan ZA. Establishing an in vitro model of salivary gland tumors. The Cutting Edge: a publication of the American Association of Pathologists Assistants. pathassist.org/surveys/?id=2015_eBlast_04.

Book Chapters
3. Khan ZA and Chakrabarti S. Glucose-induced cellular signalling in diabetic retinopathy. In: Visual Dysfunction in Diabetes: The Science of Patient Impairment and Health Care. Tombran-Tink J, Barnstable CJ, Gardner TW (Eds.). Humana Press, 13, 211-232, 2012. Print ISBN: 978-1-60761-149-3; Online ISBN: 978-1-60761-150-9https://doi.org/10.1007/978-1-60761-150-9_13.

Articles
48. Todorovich SM and Khan ZA. Elevated T-box 2 in infantile hemangioma stem cells maintains an adipogenic differentiation-competent state. Dermatoendocrinol. 2013 Jun 1;5(3):352-7. doi: 10.4161/derm.26739. Epub 2013 Nov 5. PubMed PMID: 24516689; PubMed Central PMCID: PMC3908965.

47. Kleiman A, Keats EC, Chan NG, and Khan ZA. Elevated IGF2 prevents leptin induction and terminal adipocyte differentiation in hemangioma stem cells. Exp Mol Pathol. 2013 Feb;94(1):126-36. doi: 10.1016/j.yexmp.2012.09.023. Epub 2012 Oct 6. PubMed PMID: 23047069.

46. Chen S, Chakrabarti R, Keats EC, Chen M, Chakrabarti S, Khan ZA. Regulation of vascular endothelial growth factor expression by extra domain B segment of fibronectin in endothelial cells. Invest Ophthalmol Vis Sci. 2012 Dec 17;53(13):8333-43. doi: 10.1167/iovs.12-9766. PubMed PMID: 23150625.

45. Welten CM, Keats EC, Ang LC, and Khan ZA. Hemangioblastoma stromal cells show committed stem cell phenotype. Can J Neurol Sci. 2012 Nov;39(6):821-7. doi: 10.1017/s0317167100015675. PubMed PMID: 23041404.

44. Keats E and Khan ZA. Unique responses of stem cell-derived vascular endothelial and mesenchymal cells to high levels of glucose. PLoS One. 2012;7(6):e38752. doi: 10.1371/journal.pone.0038752. Epub 2012 Jun 6. PubMed PMID: 22701703; PubMed Central PMCID: PMC3368917.

43. Roach EE, Chakrabarti R, Park NI, Keats EC, Yip J, Chan NG, and Khan ZA. Intrinsic regulation of hemangioma involution by platelet-derived growth factor. Cell Death Dis. 2012 Jun 21;3:e328. doi: 10.1038/cddis.2012.58. PubMed PMID: 22717583; PubMed Central PMCID: PMC3388230. 

42. Kleiman A, Keats EC, Chan NG, and Khan ZA. Evolution of hemangioma endothelium. Exp Mol Pathol. 2012 Oct;93(2):264-72. doi: 10.1016/j.yexmp.2012.04.020. Epub 2012 May 4. Review. PubMed PMID: 22565125.

41. Keats EC and Khan ZA. Vascular stem cells in diabetic complications: evidence for a role in the pathogenesis and the therapeutic promise. Cardiovasc Diabetol. 2012 Apr 23;11:37. doi: 10.1186/1475-2840-11-37. Review. PubMed PMID: 22524626; PubMed Central PMCID: PMC3476432.

Other works
2. MacDonald AJ and Khan ZA. Expression of blood-brain barrier-specific antigens in non-brain derived endothelial cells despite lack of astrocyte interactions. Br J Med Med Res 3, 29-40, 2013.

Book Chapters
2. Khan ZA and Chakrabarti S. Chronic diabetic complications: endothelial cells at the frontline. In: Frontiers in Cardiovascular Drug Discovery. Choudhary MI, Rahman A (Eds.). Bentham Science Publishers Ltd, 1,121-137, 2010. ISBN (Print): 978-1-60805-668-2; ISBN (Online): 978-1-60805-160-1. DOI: 10.2174/97816080516011100101.

Articles
40. Chiu J, Khan ZA, Farhangkhoee H, and Chakrabarti S. Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-kappaB. Nutrition 25:964-972, 2009. PMID: 19268536.

39. Picard A, Boscolo E, Khan ZA, Bartch TC, Mulliken JB, Vazquez MP, and Bischoff J. IGF-2 and FLT-1/VEGF-R1 mRNA levels reveal distinctions and similarities between congenital and common infantile hemangioma. Pediatr Res 63:263-267, 2008. PMID: 18287964.

38. Melero-Martin JM, De Obaldia ME, Kang SY, Khan ZA, Yuan L, Oettgen P, and Bischoff J. Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Circ Res 103:194-202, 2008. PMID: 18556575.

37. Khan ZA, Boscolo E, Picard A, Psutka S, Melero-Martin JM, Bartch TC, Mulliken JB, and Bischoff J. Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. J Clin Invest 118:2592-2599, 2008. PMID: 18535669.

36. Dudley AC, Khan ZA, Shih SC, Kang SY, Zwaans BM, Bischoff J, and Klagsbrun M. Calcification of multipotent prostate tumor endothelium. Cancer Cell 14:201-211, 2008. PMID: 18772110.

Other works
1. Khan ZA and Chakrabarti S. Response to “Inhibition of p300 and nuclear factor-κB by curcumin and its role in diabetic nephropathy”. Nutrition 25:975-976, 2009.

Articles
35. Xin X, Chen S, Khan ZA, and Chakrabarti S. Akt activation and augmented fibronectin production in hyperhexosemia. Am J Physiol Endocrinol Metab 293:E1036-1044, 2007. PMID: 17666488.

34. Melero-Martin JM, Khan ZA, Picard A, Wu X, Paruchuri S, and Bischoff J. In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood 109:4761-4768, 2007. PMID: 17327403.

33. Khan ZA and Chakrabarti S. Cellular signaling and potential new treatment targets in diabetic retinopathy. Exp Diabetes Res 2007:31867, 2007. PMID: 18288248.

32. Chen S, Khan ZA, Karmazyn M, and Chakrabarti S. Role of endothelin-1, sodium hydrogen exchanger-1 and mitogen activated protein kinase (MAPK) activation in glucose-induced cardiomyocyte hypertrophy. Diabetes Metab Res Rev 23:356-367, 2007. PMID: 17024690.

31. Siddiqui I, Khan ZA, Lian D, Jiang J, Zhong R, Garcia B, and Chakrabarti S. Endothelin-mediated oncofetal fibronectin expression in chronic allograft nephropathy. Transplantation 82:406-414, 2006. PMID: 16906041.

30. Paruchuri S, Yang JH, Aikawa E, Melero-Martin JM, Khan ZA, Loukogeorgakis S, Schoen FJ, and Bischoff J. Human pulmonary valve progenitor cells exhibit endothelial/mesenchymal plasticity in response to vascular endothelial growth factor-A and transforming growth factor-beta2. Circ Res 99:861-869, 2006. PMID: 16973908.

29. Khan ZA, Melero-Martin JM, Wu X, Paruchuri S, Boscolo E, Mulliken JB, and Bischoff J. Endothelial progenitor cells from infantile hemangioma and umbilical cord blood display unique cellular responses to endostatin. Blood 108:915-921, 2006. PMID: 16861344.

28. Khan ZA, Farhangkhoee H, Mahon JL, Bere L, Gonder JR, Chan BM, Uniyal S, and Chakrabarti S. Endothelins: regulators of extracellular matrix protein production in diabetes. Exp Biol Med (Maywood) 231:1022-1029, 2006. PMID: 16741042.

27. Khan ZA, Farhangkhoee H, and Chakrabarti S. Towards newer molecular targets for chronic diabetic complications. Curr Vasc Pharmacol 4:45-57, 2006. PMID: 16472176.

26. Khan ZA, and Chakrabarti S. Therapeutic targeting of endothelial dysfunction in chronic diabetic complications. Recent Pat Cardiovasc Drug Discov 1:167-175, 2006. PMID: 18221084.

25. Kaur H, Chen S, Xin X, Chiu J, Khan ZA, and Chakrabarti S. Diabetes-induced extracellular matrix protein expression is mediated by transcription coactivator p300. Diabetes 55:3104-3111, 2006. PMID: 17065349.

24. Farhangkhoee H, Khan ZA, Kaur H, Xin X, Chen S, and Chakrabarti S. Vascular endothelial dysfunction in diabetic cardiomyopathy: pathogenesis and potential treatment targets. Pharmacol Ther 111:384-399, 2006. PMID: 16343639.

23. Farhangkhoee H, Khan ZA, Chen S, and Chakrabarti S. Differential effects of curcumin on vasoactive factors in the diabetic rat heart. Nutr Metab (Lond) 3:27, 2006. PMID: 16848894.

Book Chapters
1. Chakrabarti S and Khan ZA. Endothelins and microvascular endothelial responses in diabetes. In: Microvascular Research: Biology and Pathology. Elsevier Science, 671-676, 2005. ISBN (Print): 0126395101; ISBN (Online): 9780126395105.

Articles
22. Xin X, Khan ZA, Chen S, and Chakrabarti S. Glucose-induced Akt1 activation mediates fibronectin synthesis in endothelial cells. Diabetologia 48:2428-2436, 2005. PMID: 16193290.

21. Khan ZA, Farhangkhoee H, Barbin YP, Adams PC, and Chakrabarti S. Glucose-induced regulation of novel iron transporters in vascular endothelial cell dysfunction. Free Radic Res 39:1203-1210, 2005. PMID: 16298746.

20. Khan ZA, Chan BM, Uniyal S, Barbin YP, Farhangkhoee H, Chen S, and Chakrabarti S. EDB fibronectin and angiogenesis - a novel mechanistic pathway. Angiogenesis 8:183-196, 2005. PMID: 16308732.

19. Khan ZA, Caurtero J, Barbin YP, Chan BM, Uniyal S, and Chakrabarti S. ED-B fibronectin in non-small cell lung carcinoma. Exp Lung Res 31:701-711, 2005. PMID: 16203624.

18. Khan ZA, Barbin YP, Farhangkhoee H, Beier N, Scholz W, and Chakrabarti S. Glucose-induced serum- and glucocorticoid-regulated kinase activation in oncofetal fibronectin expression. Biochem Biophys Res Commun 329:275-280, 2005. PMID: 15721303.

17. Fukuda G, Yoshitake N, Khan ZA, Kanazawa M, Notoya Y, Che XF, Akiyama S, Tomoda A, Chakrabarti S, and Odawara M. 2-amino-phenoxazine-3-one attenuates glucose-induced augmentation of embryonic form of myosin heavy chain, endothelin-1 and plasminogen activator inhibitor-1 in human umbilical vein endothelial cells. Biol Pharm Bull 28:797-801, 2005. PMID: 15863881.

16. Fukuda G, Khan ZA, Barbin YP, Farhangkhoee H, Tilton RG, and Chakrabarti S. Endothelin-mediated remodeling in aortas of diabetic rats. Diabetes Metab Res Rev 21:367-375, 2005. PMID: 15580650.

15. Farhangkhoee H, Khan ZA, Barbin Y, and Chakrabarti S. Glucose-induced up-regulation of CD36 mediates oxidative stress and microvascular endothelial cell dysfunction. Diabetologia 48:1401-1410, 2005. PMID: 15915335.

14. Aleryani SL, Cluette-Brown JE, Khan ZA, Hasaba H, Lopez de Heredia L, and Laposata M. Fatty acid methyl esters are detectable in the plasma and their presence correlates with liver dysfunction. Clin Chim Acta 359:141-149, 2005. PMID: 15894299.

13. Xin X, Khan ZA, Chen S, and Chakrabarti S. Extracellular signal-regulated kinase (ERK) in glucose-induced and endothelin-mediated fibronectin synthesis. Lab Invest 84:1451-1459, 2004. PMID: 15448709.

12. Kowluru RA, Kowluru A, Chakrabarti S, and Khan Z. Potential contributory role of H-Ras, a small G-protein, in the development of retinopathy in diabetic rats. Diabetes 53:775-783, 2004. PMID: 14988264.

11. Khan ZA, Cukiernik M, Gonder JR, and Chakrabarti S. Oncofetal fibronectin in diabetic retinopathy. Invest Ophthalmol Vis Sci 45:287-295, 2004. PMID: 14691186.

10. Khan ZA, Barbin YP, Cukiernik M, Adams PC, and Chakrabarti S. Heme-oxygenase-mediated iron accumulation in the liver. Can J Physiol Pharmacol 82:448-456, 2004. PMID: 15389291.

9. Cukiernik M, Hileeto D, Downey D, Evans T, Khan ZA, Karmazyn M, and Chakrabarti S. The role of the sodium hydrogen exchanger-1 in mediating diabetes-induced changes in the retina. Diabetes Metab Res Rev 20:61-71, 2004. PMID: 14737747.

8. Chen S, Khan ZA, Barbin Y, and Chakrabarti S. Pro-oxidant role of heme oxygenase in mediating glucose-induced endothelial cell damage. Free Radic Res 38:1301-1310, 2004. PMID: 15763954.

7. Chakrabarti S, Khan ZA, Cukiernik M, Zhang W, and Sima AA. C-peptide and retinal microangiopathy in diabetes. Exp Diabesity Res 5:91-96, 2004. PMID: 15198374.

Articles
6. Khan ZA and Chakrabarti S. Endothelins in chronic diabetic complications. Can J Physiol Pharmacol 81:622-634, 2003. PMID: 12839273.

5. Khan ZA and Chakrabarti S. Growth factors in proliferative diabetic retinopathy. Exp Diabesity Res 4:287-301, 2003. PMID: 14668050.

4. Farhangkhoee H, Khan ZA, Mukherjee S, Cukiernik M, Barbin YP, Karmazyn M, and Chakrabarti S. Heme oxygenase in diabetes-induced oxidative stress in the heart. J Mol Cell Cardiol 35:1439-1448, 2003. PMID: 14654370.

3. Chen S, Khan ZA, Cukiernik M, and Chakrabarti S. Differential activation of NF-kappa B and AP-1 in increased fibronectin synthesis in target organs of diabetic complications. Am J Physiol Endocrinol Metab 284:E1089-1097, 2003. PMID: 12582013.

2. Adams PC, Barbin YP, Khan ZA, and Chakrabarti S. Expression of ferroportin in hemochromatosis liver. Blood Cells Mol Dis 31:256-261, 2003. PMID: 12972034.

1. Chakrabarti S, Khan ZA, Cukiernik M, Fukuda G, Chen S, and Mukherjee S. Alteration of endothelins: a common pathogenetic mechanism in chronic diabetic complications. Int J Exp Diabetes Res 3:217-231, 2002. PMID: 12546275.